Susan K. Fried

Susan K. Fried

Auto-generated profile, based on publicly available information

Susan K. Fried

Diabetes, Obesity Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, USA

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2012 in Biology of Sex Differences
Verified
Journal Article
Open access
PDF file
KKKalypso Karastergiou
Kalypso Karastergiou
SSSteven R Smith
Steven R Smith
AGAndrew S. Greenberg
Andrew S. Greenberg
SFSusan K Fried
Susan K Fried
Women have more body fat than men, but in contrast to the deleterious metabolic consequences of the central obesity typical of men, the pear-shaped body fat distribution of many women is associated with lower cardiometabolic risk. To understand the mechanisms regulating adiposity and adipose tissue distribution in men and women, significant research attention has focused on comparing adipocyte morphological and metabolic properties, as well as the capacity of preadipocytes derived from different depots for proliferation and differentiation. Available evidence points to possible intrinsic, cell autonomous differences in preadipocytes and adipocytes, as well as modulatory roles for sex steroids, the microenvironment within each adipose tissue, and developmental factors. Gluteal-femoral adipose tissues of women may simply provide a safe lipid reservoir for excess energy, or they may directly regulate systemic metabolism via release of metabolic products or adipokines. We provide a brief overview of the relationship of fat distribution to metabolic health in men and women, and then focus on mechanisms underlying sex differences in adipose tissue biology.

1 February 2013 in Molecular Aspects of Medicine
Verified
Journal Article
Closed access
MLMi-Jeong Lee
Mi-Jeong Lee
YWYuanyuan Wu
Yuanyuan Wu
SFSusan K. Fried
Susan K. Fried

1 June 2006 in American Journal of Physiology-Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
RYRong-Ze Yang
Rong-Ze Yang
MLMi-Jeong Lee
Mi-Jeong Lee
HHHong Hu
Hong Hu
JPJessica Pray
Jessica Pray
HWHai-Bin Wu
Hai-Bin Wu
DGDa-Wei Gong
Da-Wei Gong
Central (visceral) obesity is more closely associated with insulin resistance, type 2 diabetes, and cardiovascular disease than is peripheral [subcutaneous (sc)] obesity, but the underlying mechanism for this pathophysiological difference is largely unknown. To understand the molecular basis of this difference, we sequenced 10,437 expressed sequence tags (ESTs) from a human omental fat cDNA library and discovered a novel visceral fat depot-specific secretory protein, which we have named omentin. Omentin ESTs were more abundant than many known adipose genes, such as perilipin, adiponectin, and leptin in the cDNA library. Protein sequence analysis indicated that omentin mRNA encodes a peptide of 313 amino acids, containing a secretory signal sequence and a fibrinogen-related domain. Northern analysis demonstrated that omentin mRNA was predominantly expressed in visceral adipose tissue and was barely detectable in sc fat depots in humans and rhesus monkeys. Quantative real-time PCR showed that omentin mRNA was expressed in stromal vascular cells, but not fat cells, isolated from omental adipose tissue, with >150-fold less in sc cell fractions. Accordingly, omentin protein was secreted into the culture medium of omental, but not sc, fat explants. Omentin was detectable in human serum by Western blot analysis. Addition of recombinant omentin in vitro did not affect basal but enhanced insulin-stimulated glucose uptake in both sc (47%, n = 9, P = 0.003) and omental (∼30%, n = 3, P < 0.05) human adipocytes. Omentin increased Akt phosphorylation in the absence and presence of insulin. In conclusion, omentin is a new adipokine that is expressed in omental adipose tissue in humans and may regulate insulin action.

1 March 1998 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
SFS. K. Fried
S. K. Fried
The purpose of this study was to determine whether human adi- pocytes from different depots of obese subjects produce interleukin-6 (IL-6) and whether IL-6 release is regulated by glucocorticoids. Frag- ments of omental and abdominal sc adipose tissue released immu- nodetectable IL-6 into the medium during acute incubations. Omental adipose tissue released 2-3 times more IL-6 than did sc adipose tissue. Isolated adipocytes prepared from these tissues also released IL-6 (omental . sc), but this accounted for only 10% of the total tissue release. Culture of adipose tissue fragments for 7 days with the glu- cocorticoid dexamethasone markedly suppressed IL-6 production. These data show for the first time that substantial quantities of IL-6 (up to 75 ng/mL) accumulate in the medium during incubations of both adipocytes and adipose tissue. Although little is known about the effects of IL-6 on adipose tissue, one action is a down-regulation of adipose tissue lipoprotein lipase. The regulated production of this multifunctional cytokine may modulate regional adipose tissue me- tabolism and may contribute to the recently reported correlation between serum IL-6 and the level of obesity. (J Clin Endocrinol Metab 83: 847- 850, 1998)

1 June 2007 in Diabetes
Verified
Journal Article
Open access
PDF file
CBCelia M. de Souza Batista
Celia M. de Souza Batista
RYRong-Ze Yang
Rong-Ze Yang
MLMi-Jeong Lee
Mi-Jeong Lee
NGNicole M. Glynn
Nicole M. Glynn
DYDao-Zhan Yu
Dao-Zhan Yu
JMJohn C. McLenithan
John C. McLenithan
Central obesity and the accumulation of visceral fat are risk factors for the development of type 2 diabetes and cardiovascular disease. Omentin is a protein expressed and secreted from visceral but not subcutaneous adipose tissue that increases insulin sensitivity in human adipocytes. To determine the impact of obesity-dependent insulin resistance on the regulation of two omentin isoforms, gene expression and plasma levels were measured in lean, overweight, and obese subjects. Omentin 1 was shown to be the major circulating isoform in human plasma. Lean subjects had significantly higher plasma omentin 1 levels than obese and overweight subjects. In addition, higher plasma omentin 1 levels were detected in women compared with men. Plasma omentin 1 levels were inversely correlated with BMI, waist circumference, leptin levels, and insulin resistance as measured by homeostasis model assessment and positively correlated with adiponectin and HDL levels. Both omentin 1 and omentin 2 gene expression were decreased with obesity and were highly correlated with each other in visceral adipose tissue. In summary, decreased omentin levels are associated with increasing obesity and insulin resistance. Therefore, omentin levels may be predictive of the metabolic consequences or co-morbidities associated with obesity.

1 September 2006 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
WJWenjuan Shi Jobgen
Wenjuan Shi Jobgen
SFSusan K. Fried
Susan K. Fried
WFWenjiang J. Fu
Wenjiang J. Fu
CMCynthia Meininger
Cynthia Meininger
GWGuoyao Wu
Guoyao Wu